eubiologics

Á¦Ç° ¹× ¿¬±¸°³¹ß

Development and supply of safe and effective vaccine for global public health

¹é½Å

À¯ºñÄÝ-Ç÷¯½º¢ç

À¯ºñÄÝ-Ç÷¯½º¢ç´Â Àú¼Òµæ ±¹°¡¿¡¼­ ÁÖ·Î À¯ÇàÇÏ´Â ÄÝ·¹¶ó¸¦ ¿¹¹æÇϵµ·Ï °³¹ßµÈ °æ±¸Åõ¿©¿ë Á¦Ç°À̹ǷΠÁ¢Á¾ ºÎÀ§ ÅëÁõ, ºÎÁ¾, ¹ßÁø µî ±¹¼ÒÀûÀÎ ÀÌ»ó »ç·Ê°¡ ¹ß»ýÇÏÁö ¾Ê´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ º°µµ ¿ÏÃæÁ¦°¡ ÇÊ¿ä¾ø´Â °£ÆíÇÑ º¹¿ë¹ý°ú Àú·ÅÇÑ °¡°Ý ´öºÐ¿¡ WHO, À¯¿£¾Æµ¿±â±Ý(UNICEF), ¼¼°è¹é½Å¸é¿ª¿¬ÇÕ(GAVI) µîÀ» ÅëÇØ ÄÝ·¹¶ó·Î °íÅë¹Þ°í ÀÖ´Â Àú°³¹ßµµ»ó±¹¿¡ °ø±ÞÇÏ°í ÀÖ½À´Ï´Ù. ƯÈ÷ À¯ºñÄÝ-Ç÷¯½º¢ç´Â ±âÁ¸ÀÇ À¯ºñÄݢ纸´Ù º¸°ü ¹× ¼ö¼ÛÀÌ ´õ¿í ½±°í °æ±¸ Åõ¿©°¡ °£ÆíÇÑ 1ȸ¿ë Çöó½ºÆ½Æ©ºê Á¦ÇüÀ¸·Î 2017³â 8¿ù WHO PQ¸¦ ¹Þ¾Æ ¼¼°è °¢Áö¿¡ °ø±ÞÇÏ°í ÀÖ½À´Ï´Ù.
Á¦Ç°¸í Euvichol-Plus
Á¦Ç°±¸ºÐ Àü¹®ÀǾàÇ° (¼öÃâ¿ë)
Åõ¿©¹æ¹ý °æ±¸¿ë, 2ÁÖ °£°ÝÀ¸·Î 2ȸ Åõ¿©
Á¦Ç°¼º»ó Ȳ»ö ³»Áö ¹ÌȲ»öÀ» ¶ì´Â ¿ë¾×
È¿´É/È¿°ú 1¼¼ ÀÌ»ó Àü ¿¬·ÉÃþ¿¡¼­ ÄÝ·¹¶ó ¿¹¹æ
¼Ò°³ÀÚ·á ´Ù¿î·Îµå
Euvichol-Plus

Á¦Ç°¼ººÐ

Vaccine strain Quantity
V. cholerae O1 Inaba Cairo 48 (H) 300 L.E.U*
V. cholerae O1 Inaba Phil 6973 El Tor (F) 600 L.E.U
V. cholerae O1 Ogawa Cairo 50 (F) 300 L.E.U
V. cholerae O1 Ogawa Cairo 50(H) 300 L.E.U
V. cholerae O139 4260B (F) 600 L.E.U

H:Heat inactivated F:Formalin inactivated

* LEU : Lipopolysaccharide ELISA Units

Á¦Ç°Á¤º¸

¿ë¹ý/¿ë·® ÀúÀå¹æ¹ý À¯È¿±â°£ Ư¡
2ÁÖ °£°ÝÀ¸·Î 2ȸ Åõ¿© 2¡É ~ 8¡É ³ÃÀ庸°ü Á¦Á¶ÀϷκÎÅÍ 24°³¿ù Plastic tube presentation (Durable, light plastic tube / No buffer required)


Á¦Ç° ±¸¸Å °ü·Ã ¹®ÀÇ»çÇ×Àº sales@eubiologics.comÀ¸·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù.